Bulk ingredients

(Image: BernardaSv)

AMRI awarded seven-year NIH contract

By Melissa Fassbender

AMRI will support the development and manufacture of active pharmaceutical ingredients (API) and drug product for Phase I clinical studies under a seven-year contract with the NIH.

(Image: WuXi AppTec Co., Ltd.)

WuXi AppTec IPO tops $353m

By Melissa Fassbender

The Chinese contract research and development company WuXi AppTec has raised more than $353m in its initial public offering of common stock on the Shanghai Stock Exchange.

(Image: iStock/daizuoxin)

News in brief

BioDuro teams up with API developer Porton

By Melissa Fassbender

The San Diego-CA-based contract research, development, and manufacturing organization (CDMO), BioDuro, has announced a cooperation agreement with Porton Pharma Solutions.